Feprazone
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
4-(3-methylbut-2-enyl)-1,2-di(phenyl)pyrazolidine-3,5-dione | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| ATC code | M02AA16 (WHO) |
| PubChem | CID 35455 |
| ChemSpider |
32612 |
| UNII |
7BVX6J0CGR |
| KEGG |
D01305 |
| Chemical data | |
| Formula | C20H20N2O2 |
| Molar mass | 320.385 g/mol |
| |
| |
| (verify) | |
Feprazone (or prenazone) is a drug used for joint and muscular pain.[1]
It is an analog of butazone but instead of a n-butyl group it is prenylated.
References
- ↑ Koyama, T.; Izawa, Y.; Wada, H.; Makita, T.; Hashimoto, Y.; Enomoto, M. (1982). "Toxicological aspects of feprazone, a new nonsteroidal anti-inflammatory drug". Toxicology and applied pharmacology 64 (2): 255–270. doi:10.1016/0041-008X(82)90222-8. PMID 7123554.
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Tuesday, April 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
